Ashva's iMAGIC imaging software:
This article was originally published in Clinica
Indian firm Ashva Technologies has received 510(k) clearance from the US FDA for its iMAGIC imaging software. The technology has been approved for a variety of tasks, including ultrasound image archiving, manipulation, creation of template-based reporting and burning the image onto media such as a CD or DVD. The Chennai-based firm claims to have installed over 500 iMAGIC units in Asia. The company also has US offices in Corinth, Texas, and a Malaysian facility in Selangor Darul Ehsan.
You may also be interested in...
US FDA declines to review the CCR5 antagonist for use in highly treatment-experienced HIV patients. Safety data from an ongoing study should be sufficient to address the agency’s concerns about the higher 700mg dose, CytoDyn management says, but FDA also has questions about the production of the self-injectable syringes.
Mallinckrodt's drug to treat hepatorenal syndrome met its primary endpoint of HRS reversal but FDA wants reassurance that this surrogate endpoint translates into a treatment effect on clinical outcomes. A greater incidence of respiratory failure in those receiving terlipressin "remains a significant safety concern," the agency says.
Lead immuno-oncology asset NC318 targeting Siglec-15 showed encouraging early activity in patients refractory to PD-1/L1 inhibitors, but now Phase II plans are scuttled in lung and ovarian cancers.